Keratoconus: Progressive Corneal Thinning

Roughly 1 in 375 people in the general population has keratoconus, a figure that jumped substantially upward when a 2017 Dutch population study using modern corneal tomography revised older estimates that had placed prevalence closer to 1 in 2,000 (Godefrooij et al., 2017 — JAMA Ophthalmology). That gap between the old number and the new one tells an important story: keratoconus was never rare — it was under-detected.

What Happens to the Cornea

The cornea, that clear dome-shaped front surface of the eye, depends on a highly organized lattice of collagen fibrils for its shape and optical clarity. In keratoconus, enzymatic degradation and biomechanical weakening cause this lattice to lose structural integrity. The cornea progressively thins — often most pronounced in the inferior or paracentral zone — and bulges forward into a cone-like shape.

This distortion produces irregular astigmatism that standard glasses struggle to correct. Visual acuity drops, ghost images appear, and light sources develop streaky halos. The condition typically presents during the teenage years and can progress through the twenties and thirties before stabilizing, though the timeline varies considerably between individuals (National Eye Institute).

Risk Factors Worth Knowing

Genetics play a confirmed role. First-degree relatives of affected individuals carry a risk roughly 15 to 67 times higher than the general population, depending on the study population examined (National Library of Medicine — GeneReviews). But genetics alone does not explain the full picture.

Chronic eye rubbing stands out as one of the strongest modifiable risk factors — and this is the detail that deserves emphasis because it is actionable. Atopic conditions such as allergic conjunctivitis, eczema, and asthma drive habitual rubbing, and the mechanical shear stress accelerates collagen degradation in a cornea already predisposed to weakness. Connective tissue disorders like Ehlers-Danlos syndrome and Down syndrome also carry elevated keratoconus rates, reinforcing the link between systemic collagen abnormalities and corneal vulnerability.

Diagnosis: Beyond the Eye Chart

A slit-lamp exam can reveal classic signs — Vogt striae (fine vertical stress lines in the deep stroma), Fleischer rings (iron deposits at the base of the cone), and corneal thinning visible on retroillumination. But waiting for those clinical signs means catching keratoconus after meaningful progression has already occurred.

Modern diagnosis relies on corneal tomography, particularly Scheimpflug-based imaging systems like the Pentacam, which map anterior and posterior corneal elevation, pachymetry (thickness distribution), and curvature with micron-level precision. A normal central corneal thickness hovers around 540 micrometers; keratoconic corneas can thin to below 400 micrometers in advanced cases. Posterior elevation changes often appear before anterior surface irregularities become clinically obvious, making tomography the single most valuable screening tool for early-stage disease.

Treatment: A Ladder, Not a Single Step

Management follows a staged approach based on disease severity and progression status.

Spectacles and soft contact lenses work adequately in mild keratoconus where irregular astigmatism remains modest. As the cone advances, rigid gas-permeable (RGP) lenses or scleral lenses — which vault over the cornea entirely and rest on the sclera — become the optical correction of choice. Scleral lenses, in particular, have transformed quality of life for moderate-to-advanced keratoconus patients by creating a smooth refractive surface over even highly irregular corneas.

Corneal collagen cross-linking (CXL) represents the only treatment that addresses progression itself rather than just optical correction. The FDA approved the first CXL system (the KXL system with Photrexa Viscous) in 2016 for progressive keratoconus (U.S. FDA). The procedure uses riboflavin (vitamin B2) drops combined with ultraviolet-A light at 370 nm to induce new covalent bonds between collagen fibrils in the anterior stroma. Clinical trials demonstrated that CXL halted progression in approximately 95% of treated eyes over a three-year follow-up period, with modest flattening of the cone in a subset of patients.

Intrastromal corneal ring segments (ICRS) — small arc-shaped implants placed within the corneal stroma — can reduce irregular astigmatism and improve contact lens tolerance. They do not halt progression and are often paired with CXL.

Corneal transplantation remains a last-resort option when the cornea is too thin, too scarred, or too irregular for contact lens wear. Penetrating keratoplasty (full-thickness graft) and deep anterior lamellar keratoplasty (DALK, which preserves the recipient's endothelium) are the two main surgical approaches. The Cornea Donor Study reported five-year graft survival rates above 86% for keratoconus-related transplants, among the best outcomes for any transplant indication (NEI-supported Cornea Donor Study).

Why Early Detection Matters

The practical argument for screening is straightforward: CXL can only preserve existing corneal integrity. Collagen that has already degraded cannot be restored. Detecting keratoconus before significant thinning and scarring develop — ideally through routine corneal tomography in at-risk populations — expands the treatment window and can prevent the need for transplantation entirely.

Ophthalmologists and optometrists screening adolescents with atopic disease, a family history of keratoconus, or unexplained progressive astigmatism play a critical role in shifting outcomes from reactive surgery to proactive stabilization.

Frequently Asked Questions

Does keratoconus always require surgery?

No. The majority of keratoconus patients are managed with specialty contact lenses and, when progression is documented, corneal cross-linking. Only an estimated 10–20% of keratoconus patients ultimately require corneal transplantation (National Eye Institute).

Can rubbing the eyes actually cause keratoconus?

Chronic, vigorous eye rubbing is strongly associated with keratoconus onset and progression. While it may not single-handedly cause the condition in the absence of genetic susceptibility, the mechanical stress is believed to be a significant contributing factor — and stopping the habit is universally recommended by corneal specialists.

At what age does keratoconus stop progressing?

Progression most commonly slows in the mid-thirties to forties, though this is a general pattern rather than a rule. Some individuals experience progression beyond age 40, and corneal cross-linking provides a way to halt the process independent of age-related stabilization.

Is keratoconus the same as astigmatism?

Not exactly. Regular astigmatism arises from symmetric curvature differences and is easily corrected with glasses or standard contact lenses. Keratoconus produces irregular astigmatism from asymmetric corneal thinning and protrusion, which standard lenses cannot fully correct.

References

• National Eye Institute — Keratoconus
• U.S. FDA — Approval of Corneal Cross-Linking (2016)
• Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RPL. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. JAMA Ophthalmology. 2017;135(5):486-491.
• GeneReviews — Keratoconus, National Library of Medicine
• NEI Cornea Donor Study — ClinicalTrials.gov

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)